Medpace Holdings, Inc. 10-Q

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds Share Repurchases This table provides certain information with respect to our monthly repurchases of the Company’s common stock during the first quarter of fiscal year 2023: Period Total Number of Shares Purchased Average Price Paid Per Share Total Number of Shares Purchased as Part of Publically Announce Plan Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plan January 1, 2023, through January 31, 2023 65,415 $ 208.79 7,317,784 $ 439,168,043 February 1, 2023, through February 28, 2023 25,800 $ 207.17 7,343,584 $ 433,822,983 March 1, 2023 through March 31, 2023 563,572 $ 179.43 7,907,156 $ 332,703,493 Total 654,787 $ 183.45 7,907,156 All share repurchases were made using cash resources and executed pursuant to established Rule 10b5-1 trading plans. Our share repurchases may occur through open market purchases or negotiated transactions. The above table excludes shares repurchased to settle employee tax withholding related to the vesting of stock awards. We returned $120.1 million to shareholders in the form of share repurchases in the first quarter of fiscal year 2023. Refer to Note 1 – Basis of Presentation of the Notes to Consolidated Financial Statements (Part I, Item 1 of this Form 10-Q) for further discussion regarding share repurchases. Use of Proceeds from Registered Securities Not applicable. Item 3. Defaults Upon Senior Securities None. Item 4. Mine Safety Disclosures Not applicable.